Resources & Training

SCRS Oncology Program Welcomes New Board Members

November 27, 2023 Press

November 27, 2023 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, has announced additions to its Oncology Program Board.

The SCRS Oncology Program is dedicated to advancing the sustainability and effectiveness of oncology sites by identifying their unique needs and creating strategic resources to address these challenges. Through collaboration with corporate and site partners, our mission is to foster a dynamic environment that encourages the identification and development of solutions for the oncology research community.

The newly appointed members were carefully selected based on their extensive expertise and rich experience in the field of oncology research. The recently added members of the Oncology Board include:

Courtney Alexander, Senior Operations Manager & Contract and Budget Specialist, Centricity Research
Radhika Butala, Clinical Trial & Research Unit Manager, Westmead Private Hospital (Part of Ramsay Health Care & Ramsay Clinical Trials Network)
Angela Fritsche, Operations Administrator, Mayo Clinic Comprehensive Cancer Center Clinical Trials Office
Angela Galindo, Director of Site Development & Quality Assurance, The START Center for Cancer Care
Jennifer Hunter, Director of Research Operations, Mary Crowley Cancer Center
Zin Htway, Supervisor & Operations Manager of Anatomic Pathology, HCA Los Robles Hospital & Medical Center
Jessica Moehle, Senior Clinical Research Administrative Director, Huntsman Cancer Institute
Thobekile Mthethwa-Pitt, Trial Hub Senior Education & Quality Manager, Alfred Health
John Musser, Senior Director, Clinical Research Administration, Florida Cancer Specialists & Research Institute
Lynda Owen, Associate Director, Research Program Development & Education, Duke Cancer Network
Sevtap Rowlands, Director of Clinical Operations, 4 Medical Clinical Solutions
T.J. Sharpe, Patient Engagement Program Manager, Medidata Solutions
Johnny Walker, Director of Research, Utah Cancer Specialists
Rachel Wong, Clinical Trials Unit Manager, Gallipoli Medical Research Foundation

Jimmy Bechtel, SCRS VP of Site Engagement, shared, “As SCRS continues its mission to advance the sustainability and effectiveness of oncology sites, the unique insights and expertise of our newly appointed members will play a pivotal role in identifying and developing resources that will benefit the entire oncology research community. Their dedication to creating opportunities for innovation and excellence in oncology research will undoubtedly shape the future of the program.”

To learn more about the SCRS Oncology Program visit myscrs-new.local/about/scrs-oncology-program.

About the Society for Clinical Research Sites

The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

Science 37 Joins SCRS Global Impact Partner Program

November 2, 2023 – The Society for Clinical Research Sites (SCRS) is proud to announce a strategic Global Impact Partnership with Science 37, marking the Society’s first and only fully virtual clinical trial site to participate in its expansive Global Impact Partner community. “We are excited to announce our partnership with SCRS,” said David Coman, CEO of Science 37. “The Science 37 Metasite™ is at the forefront of a clinical research shift, as it breaks down geographical barriers and makes clinical trials more accessible. We look forward to collaborating with the SCRS team, along with its network of clinical research sponsors and sites to deliver a more patient-friendly and impactful research ecosystem.” Science 37’s unique model reaches patients who do not have access to traditional brick-and-mortar clinical trial sites and enables them to participate from the comfort of their homes. Oversight is managed by telemedicine investigators, physical procedures are managed by mobile nurses, and patient support is provided by remote coordinators. The experience is powered by a proprietary platform that enables data collection and workflow orchestration that drives greater compliance to produce high-quality data. Marcus Maleck, Vice President of Global Business Partnerships with SCRS also expressed enthusiasm about the collaboration, stating, “Science 37 is a pioneer in our industry ever since launching their decentralized clinical trials platform. Now, as the clinical research landscape evolves, they are incorporating their technology and expertise to expand patient access to trials. Their work in clinical trial innovation is invaluable to our site members and the industry as a whole. We look forward to collaborating towards our shared goal of empowering site success.” For more information about SCRS Global Impact Partners, visit scrsprograms.com. For more information about the Science 37 Metasite, visit www.science37.com. About the Society for Clinical Research Sites The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success. About Science 37Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through our Metasite™ we reach an expanded population beyond the traditional site, delivering on our goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own homes, at their local community provider, or at a traditional site when needed. Our Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.

SCRS Unveils Evolution of Diversity-Focused Program & Summit

January 11, 2024 – The Society for Clinical Research Sites (SCRS) is proud to introduce the evolution of its growing Diversity Site Solutions Summit and Diversity Awareness Program. In response to the increasing imperative for inclusive clinical trials, the Diversity Summit will now be rebranded as the “IncluDE Site Solutions Summit” and the Diversity Awareness Program will be known as the “IncluDE Program”. The updated names signify a pivotal moment for SCRS and industry partners working to enable more diverse, equitable and inclusive clinical trials. Both programs will continue to champion diverse clinical trial participation by sharing proprietary research, resources and guidance to ensure clinical research reflects the rich tapestry of the global population. “SCRS feels that ‘IncluDE’ better reflects the objectives of these critical programs, which is assuring clinical research is inclusive and equitable for all communities that want to participate,” said Jackie Kent, Vice President of Diversity & Special Projects at SCRS. “Diversity often focuses on race and ethnicity, while inclusivity spans gender identity, sexual orientation, religion, persons with disabilities, socioeconomic status and more. As the industry works towards more accessible clinical trials, we must prioritize making all communities feel that they are truly welcome and able to participate in life-changing research.” With a heightened focus on inclusive practices, the programs will continue to serve as a premier platform for industry stakeholders to collaboratively advance initiatives that empower underrepresented populations to access clinical trials and healthcare. The third annual IncluDE Site Solutions Summit will be held at the Loews Hotel in Atlanta, Georgia from April 8-9, 2024. About the Society for Clinical Research Sites The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

Welcome to the Society for Clinical Research Sites

The Society for Clinical Research Sites (SCRS) is exclusively dedicated to representing and unifying the voice of the global clinical research site community, and our membership puts that to work for your site.

Fueled by Industry Collaboration

Advocacy & Initiatives

Publications

Training & Resources